Effect of 4-demethoxydaunorubicin (4-DMDR) in chronic myeloid leukemia in blastic transformation and relapsed acute leukemias.
作者信息
Bandini G, Comotti B, Scapoli G, Leoni F, Di Prisco U, Mangoni L, Battista R, Tura S
出版信息
Haematologica. 1985 Mar-Apr;70(2):155-9.
PMID:3924779
Abstract
摘要
相似文献
1
2
4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.4-去甲氧柔红霉素（伊达比星）治疗难治性或复发性急性白血病：一项初步研究。
Cancer. 1985 Apr 1;55(7):1452-4. doi: 10.1002/1097-0142(19850401)55:7<1452::aid-cncr2820550705>3.0.co;2-d.
3
4
5
4-Demethoxydaunorubicin (idarubicin) in refractory or relapsed acute leukemias.4-去甲氧柔红霉素（伊达比星）用于难治性或复发性急性白血病。
Haematologica. 1984 Nov-Dec;69(6):767-8.
6
7
Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin.口服及静脉注射4-去甲氧基柔红霉素的I期临床评估
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1187-9. doi: 10.1016/0277-5379(85)90013-6.
8
[Carminomycin in the therapy of leukemias].
Antibiotiki. 1982 Aug;27(8):632-5.
9
Daunorubicin. Results in childhood leukaemia.柔红霉素。用于治疗儿童白血病。
Arch Dis Child. 1972 Apr;47(252):272-7. doi: 10.1136/adc.47.252.272.
10
Phase II study of idarubicin administered i.v. to pediatric patients with acute lymphoblastic leukemia.
Cancer Treat Rep. 1987 Sep;71(9):855-6.
引用本文的文献
1
Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.伊达比星（4-去甲氧基柔红霉素）。临床前和临床研究的初步概述。
Invest New Drugs. 1986;4(1):85-105. doi: 10.1007/BF00172021.
2
Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.伊达比星。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。
Drugs. 1991 Oct;42(4):690-719. doi: 10.2165/00003495-199142040-00010.
Zotero 插件